MCFARLANE NEIL F. (President and CEO) sold 8.1% of their position (19.50K shares) of ZEVRA THERAPEUTICS, INC. on the open market
Open‑market sale worth $210.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/10/2025ACC: 0001681098-25-000005
DirectorOfficer· President and CEO
Since Feb 2026
-19.50K
Net shares
Net seller
$210.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
50K acquired · 69.50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+50K
Price / share
—
Trade value
—
% of position
26.1%
10/10/2025
191.52K→241.52K
Common Stock
Direct
Shares
−19.50K
Price / share
$10.82
Trade value
$210.91K
% of position
8.1%
10/10/2025
241.52K→222.02K
Total
Net shares
+30.50K
Net value
-$210.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/10/2025 | M · Option Exercise | +50K | — | — | 26.1% | 191.52K | 241.52K |
| Common Stock Direct | 10/10/2025 | S · Sale | −19.50K | $10.82 | $210.91K | 8.1% | 241.52K | 222.02K |
| Total | +30.50K | -$210.91K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
50K shares
Shares
−50K
Strike price
0
Held after
100K
Exercisable
—
10/10/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock50K shares | 10/10/2025 | M · Option Exercise | −50K | 0 | — | 100K |